New Oral Drug Targets a Resistant Cholesterol Marker

An oral treatment in development could revolutionize the management of resistant cholesterol.

Published 3h1 sourceNotable

≈ 18sSpeed

The fact

This drug targets a marker previously difficult to control, despite existing treatments.

Clinical trials may offer an alternative for patients at a therapeutic dead end.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on August 30, 2026